Colin Kealey Presents NeuroSigma at LSI USA '23

NeuroSigma's Monarch external trigeminal nerve stimulation (eTNS) device is an innovative, medication-free treatment alternative for children with ADHD.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Colin Kealey
Colin Kealey
President & CEO, NeuroSigma